Literature DB >> 15728132

Xenon: elemental anaesthesia in clinical practice.

Robert D Sanders1, Daqing Ma, Mervyn Maze.   

Abstract

The 'noble' gases have been known to have anaesthetic properties for 50 years yet only recently has their application become a clinical reality. In this review we describe the preclinical and clinical studies that have led to a resurgence of interest in the use of the element xenon as an anaesthetic. Furthermore, we highlight specific areas where xenon demonstrates advantages over other anaesthetics, including safety, beneficial pharmacokinetics, cardiovascular stability, analgesia and neuroprotection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15728132     DOI: 10.1093/bmb/ldh034

Source DB:  PubMed          Journal:  Br Med Bull        ISSN: 0007-1420            Impact factor:   4.291


  15 in total

1.  Anesthesia, analgesia, and euphoria.

Authors:  Betty J Gaffney
Journal:  Biophys J       Date:  2006-10-06       Impact factor: 4.033

2.  Bubbles, gating, and anesthetics in ion channels.

Authors:  Roland Roth; Dirk Gillespie; Wolfgang Nonner; Robert E Eisenberg
Journal:  Biophys J       Date:  2008-01-30       Impact factor: 4.033

3.  Recording Brain Electromagnetic Activity During the Administration of the Gaseous Anesthetic Agents Xenon and Nitrous Oxide in Healthy Volunteers.

Authors:  Andria Pelentritou; Levin Kuhlmann; John Cormack; Will Woods; Jamie Sleigh; David Liley
Journal:  J Vis Exp       Date:  2018-01-13       Impact factor: 1.355

4.  Argon neuroprotection.

Authors:  Robert D Sanders; Daqing Ma; Mervyn Maze
Journal:  Crit Care       Date:  2010-02-22       Impact factor: 9.097

Review 5.  Anaesthetic-related neuroprotection: intravenous or inhalational agents?

Authors:  Daniela Schifilliti; Giovanni Grasso; Alfredo Conti; Vincenzo Fodale
Journal:  CNS Drugs       Date:  2010-11       Impact factor: 5.749

6.  Recovery index, attentiveness and state of memory after xenon or isoflurane anaesthesia: a randomized controlled trial.

Authors:  Ralph Stuttmann; Jens Jakubetz; Kati Schultz; Claudia Schäfer; Sebastian Langer; Utz Ullmann; Peter Hilbert
Journal:  BMC Anesthesiol       Date:  2010-05-07       Impact factor: 2.217

7.  Large production system for hyperpolarized 129Xe for human lung imaging studies.

Authors:  F William Hersman; Iulian C Ruset; Stephen Ketel; Iga Muradian; Silviu D Covrig; Jan Distelbrink; Walter Porter; David Watt; Jeffrey Ketel; John Brackett; Aaron Hope; Samuel Patz
Journal:  Acad Radiol       Date:  2008-06       Impact factor: 3.173

Review 8.  Cellular signaling pathways and molecular mechanisms involving inhalational anesthetics-induced organoprotection.

Authors:  Lingzhi Wu; Hailin Zhao; Tianlong Wang; Chen Pac-Soo; Daqing Ma
Journal:  J Anesth       Date:  2014-03-09       Impact factor: 2.078

9.  XENON in medical area: emphasis on neuroprotection in hypoxia and anesthesia.

Authors:  Ecem Esencan; Simge Yuksel; Yusuf Berk Tosun; Alexander Robinot; Ihsan Solaroglu; John H Zhang
Journal:  Med Gas Res       Date:  2013-02-01

10.  Preconditioning triggered by carbon monoxide (CO) provides neuronal protection following perinatal hypoxia-ischemia.

Authors:  Cláudia S F Queiroga; Simone Tomasi; Marius Widerøe; Paula M Alves; Alessandro Vercelli; Helena L A Vieira
Journal:  PLoS One       Date:  2012-08-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.